SCHEMBL24758262

SCHEMBL24758262

O=C(O)c1c(C(F)(F)F)cnn1CC1CCC(F)(F)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 2/20 0.35
KDM5B Q9UGL1 2/20 0.35
KDM4C Q9H3R0 1/20 0.35
IL1B P01584 2/20 0.35
P2RX7 Q99572 2/20 0.35
GRM2 Q14416 1/20 0.34
FFAR4 Q5NUL3 3/20 0.33
CRHR1 P34998 3/20 0.32
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
CNR2 P34972 1/20 0.31
LMNA P02545 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
BCL2L1 Q07817 1/20 0.30
JAK2 O60674 1/20 0.30
JAK1 P23458 1/20 0.30
TYK2 P29597 1/20 0.30
JAK3 P52333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24906333 0.87 LMNA (0.41) KDM4CP2RX7GRM2CRHR1AKR1C3
SCHEMBL24758139 0.87 LMNA (0.38) KDM4CP2RX7GRM2CRHR1AKR1C3
SCHEMBL24758349 0.86 P2RX7 (0.32) IL1BP2RX7LMNA
SCHEMBL24758405 0.86 LMNA (0.43) KDM4CP2RX7GRM2LMNA
SCHEMBL24758351 0.86 LMNA (0.43) KDM4CP2RX7GRM2LMNA
SCHEMBL24758344 0.84 EED (0.37) GRM2CRHR1CNR2
SCHEMBL24757737 0.81 IRAK4 (0.32)
SCHEMBL30107034 0.81 POLB (0.43) AKR1C3AKR1C2TYK2
SCHEMBL24758976 0.80 AKR1C3 (0.40) IL1BP2RX7AKR1C3AKR1C2
SCHEMBL30141407 0.75 AKR1C3 (0.46) IL1BP2RX7AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES SCN8A, SCN1A, SCN7A KDM5A 2251/4885KDM5B 3146/4885KDM4C 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.